Latest news

Insights

Will AI Replace Traditional CRO Models in Clinical Research?

Executive Summary Artificial intelligence is reshaping clinical research, but it is not simply replacing existing operational models—it is redistributing how...
Insights

The New Competitive Advantage in Life Sciences: Real-Time Data Intelligence

Executive Summary Life sciences organizations are entering a new era where competitive advantage is increasingly defined not only by scientific...
Regulatory

Following FDA hold, Aardvark will examine phase 3 data early

Aardvark Therapeutics is set to disclose results from its phase 3 Prader-Willi syndrome (PWS) development program following the FDA's...
Manufacturing

Takeda Plans 4,500 Job Cuts as CEO Transition and Three Drug Launches Approach

Takeda has outlined plans to reduce around 4,500 roles during its 2026 fiscal year as part of a multiyear...
Clinical

Good News For Enterprise As It Announces Phase 2 Cystic Fibrosis Victory

A phase 2 study of Enterprise Therapeutics’ cystic fibrosis...
Insights

What Happens When AI Becomes a Scientific Co-Pilot?

Executive Summary Artificial intelligence is rapidly evolving from a background...
Insights

Digital Twins in Healthcare: Hype, Reality, and Future Applications

Executive Summary Digital twins are emerging as one of the most strategically significant — and heavily debated — innovations in...
Insights

How Pharmaceutical Companies Are Using AI for Faster Regulatory Submissions

Executive Summary Pharmaceutical companies are increasingly using artificial intelligence to accelerate regulatory submissions, improve compliance workflows, and reduce the operational...
Commercial

Novo Pens Deal With Cellular Intelligence to Advance Parkinson’s Cell Therapy

Over six months after Novo Nordisk withdrew from the cell therapy sector, its Parkinson’s disease program appears to have...
Uncategorized

Partner Therapeutics’ Bizengri Grabs FDA Green Light

The FDA’s seventh approval under its pilot program highlights...
Manufacturing

Daiichi Revises ADC Supply Plans After Changes in Cancer Drug Demand Forecasts

Daiichi Sankyo said changes in projected demand for several...
Clinical

Lilly Studies Show Weight Loss Maintenance After Switching to Foundayo or Lower-Dose Zepbound

Patients who moved from higher-dose injectable incretin therapies to Eli Lilly’s obesity pill Foundayo or to a lower dose...
Insights

5 Life Sciences Trends Defining the Next Decade of Healthcare Innovation

Executive Summary The life sciences industry is entering a transformative decade driven by artificial intelligence, precision medicine, digital health infrastructure,...
Insights

Can AI Reduce Drug Development Costs Without Increasing Risk?

Executive Summary Yes—AI can reduce drug development costs without proportionally increasing risk, but only when deployed within structured scientific, regulatory,...
Regulatory

Following FDA hold, Aardvark will examine phase 3 data early

Aardvark Therapeutics is set to disclose results from its...
Editorial Team -
Commercial

Sinopharm and TSB’s Covid-19 antibody treatment is set to hit the Chinese market

The two partners will proceed with distribution of Brii...
Commercial

Eli Lilly Invests $250 Million to Strengthen Ties with Purdue University

Eli Lilly is deepening its investment in Indiana by...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Regulatory

Following FDA hold, Aardvark will examine phase 3 data early

Aardvark Therapeutics is set to disclose results from its...
Editorial Team -
Insights

The New Competitive Advantage in Life Sciences: Real-Time Data Intelligence

Executive Summary Life sciences organizations are entering a new era...
Regulatory

Following FDA hold, Aardvark will examine phase 3 data early

Aardvark Therapeutics is set to disclose results from its...
Manufacturing

Takeda Plans 4,500 Job Cuts as CEO Transition and Three Drug Launches Approach

Takeda has outlined plans to reduce around 4,500 roles...
Clinical

Alkermes Reports Positive Phase 3 Results for Lumryz in Idiopathic Hypersomnia

Alkermes reported that its phase 3 Revitalyz study of...

Research & Development

Market Access

Manufacturing

Cellares Raises $257 Million Series D to Expand Global Cell Therapy Manufacturing

Cellares has raised $257 million in a Series D...
Manufacturing

Recipharm Commissions Bengaluru Facility for Nonbacterial Beta-Lactam Tablet Manufacturing

Swedish contract development and manufacturing organization (CDMO) Recipharm has...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Will AI Replace Traditional CRO Models in Clinical Research?

Executive Summary Artificial intelligence is reshaping clinical research, but it...
Editorial Team -
Regulatory

Following FDA hold, Aardvark will examine phase 3 data early

Aardvark Therapeutics is set to disclose results from its...
Editorial Team -